Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: A single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers
Jung, Jinah, MD, Choi, Sangmin, MD, PhD, Cho, Sang Heon, MD, PhD, Ghim, Jong-Lyul, MD, PhD, Hwang, Aekyung, MS, Kim, Unjib, MD, Kim, Bong Sik, MD, Koguchi, Atsushi, DVM, PhD, Miyoshi, Shinji, MS, Okabe, Hirotaka, MS, Bae, Kyun-Seop, MD, PhD, Lim, Hyeong-Seok, MD, PhD
Published in Clinical therapeutics (01.06.2010)
Published in Clinical therapeutics (01.06.2010)
Get full text
Journal Article